Table of contents

Therapeutics

• Review: a home-like birth environment has beneficial effects on labour and delivery (1 July, 2002)
• Review: antibiotics improve maternal and fetal outcomes and are safe in preterm, prelabour rupture of membranes (1 July, 2002)
• Review: interventions that lower cholesterol concentrations or blood pressure in diabetic patients prevent cardiovascular disease (1 July, 2002)
• Review: glycoprotein IIb/IIIa inhibitors reduced death or myocardial infarction in acute coronary syndromes not routinely scheduled for revascularisation (1 July, 2002)
• Treating isolated systolic hypertension prevented major cardiovascular events across strata of risk in older patients (1 July, 2002)
• Review: antiplatelet treatment prevents occlusive vascular events in high risk patients (1 July, 2002)
• Review: aspirin reduces CAD events in people with no history of cardiovascular disease, but it increases gastrointestinal bleeding (1 July, 2002)
• A preoperative smoking intervention decreased postoperative complications in elective knee or hip replacement (1 July, 2002)
• Oral dexamethasone led to fewer treatment failures than did nebulised dexamethasone or placebo in children with mild croup (1 July, 2002)
• Growth rate was greater with fluticasone propionate than with beclomethasone dipropionate in children with chronic asthma (1 July, 2002)
• Cardiac pacing reduced non-accidental falls in older adults with cardioinhibitory carotid sinus hypersensitivity (1 July, 2002)
• Review: intrinsic and environmental risk factor modification reduces falls in elderly people (1 July, 2002)
• Adding intranasal fluticasone to cefuroxime resolved acute rhinosinusitis (1 July, 2002) Free
• Review: oral and intravaginal agents are equally effective for treatment of uncomplicated vulvovaginal candidiasis (1 July, 2002)
• Verbal advice plus an information leaflet reduced antibiotic use in acute bronchitis (1 July, 2002)
• Low dose budesonide improved asthma control in mild asthma; adding formoterol improved control in corticosteroid treated patients (1 July, 2002)
• Sildenafil improved erectile dysfunction and quality of life in men with comorbid mild to moderate depression (1 July, 2002)
• A multidisciplinary community based rehabilitation programme improved social functioning in severe traumatic brain injury (1 July, 2002)
• Rofecoxib, 25 mg/day, was more effective than rofecoxib, 12.5 mg/day, celecoxib, or acetaminophen in osteoarthritis of the knee (1 July, 2002)
• Review: behavioural interventions plus laxatives are effective for defaecation disorders, but biofeedback does not add benefit (1 July, 2002)
• Naltrexone for 3 or 12 months did not reduce drinking in alcohol dependence (1 July, 2002)